By Samanth Subramanian, Quartz
The US’ vast shortage in infant formula has one immediate cause: the suspension of operations in an Abbott Laboratories plant in Michigan earlier this year, after samples of a lethal bacteria were found in it. But beyond that lies a bigger structural problem plaguing the American economy: a tendency for many sectors to be controlled by a few companies, or even just one.
The baby food sector, for instance, is an oligopoly, in which two companies—Abbott and the Reckitt-owned Mead Johnson—dominate three-quarters of the market by sales. Further, the federal Women, Infants and Children (WIC) program, which offers supplemental nutrition for low-income families, buys and distributes nearly half of all baby formula in the US. The WIC program contracts with a specific company in each state, setting up a de facto monopoly situation. Abbott is the WIC’s contracted supplier in 34 states.
Featured News
FIFA Faces Antitrust Lawsuit in US Federal Court Over Puerto Rico Soccer Dispute
Nov 26, 2024 by
CPI
US Judge Orders No Delay in Google Antitrust Trial Despite Potential Shift in Administration
Nov 26, 2024 by
CPI
Google Revamps Search Results in Europe Amid EU Scrutiny
Nov 26, 2024 by
CPI
Tech Giants Urge Australian Government to Delay Controversial Social Media Bill
Nov 26, 2024 by
CPI
EU’s Margrethe Vestager Urges Regulators to Be ‘Bolder’ as She Steps Down
Nov 26, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Remedies Revisited
Oct 30, 2024 by
CPI
Fixing the Fix: Updating Policy on Merger Remedies
Oct 30, 2024 by
CPI
Methodology Matters: The 2017 FTC Remedies Study
Oct 30, 2024 by
CPI
U.S. v. AT&T: Five Lessons for Vertical Merger Enforcement
Oct 30, 2024 by
CPI
The Search for Antitrust Remedies in Tech Leads Beyond Antitrust
Oct 30, 2024 by
CPI